Takeda Pharma A/S
- A10 - Antidiabéticos
- GLUBRAVA tablet 850 mg+15 mg
- GLUSTIN tablet 15 mg
- GLUSTIN tablet 30 mg
- INCRESYNC film-coated tablet 30 mg+12.5 mg
- INCRESYNC film-coated tablet 30 mg+25 mg
- INCRESYNC film-coated tablet 45 mg+12.5 mg
- INCRESYNC film-coated tablet 45 mg+25 mg
- VIPDOMET film-coated tablet 1 000 mg+12.5 mg
- VIPDOMET film-coated tablet 850 mg+12.5 mg
- VIPIDIA film-coated tablet 12.5 mg
- VIPIDIA film-coated tablet 25 mg
- VIPIDIA film-coated tablet 6.25 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- EDARBI tablet 20 mg
- EDARBI tablet 40 mg
- EDARBI tablet 80 mg
- L01 - Antineoplásicos
- ADCETRIS powder for solution for infusion 50 mg
- ALUNBRIG film-coated tablet 180 mg
- ALUNBRIG film-coated tablet 30 mg
- ALUNBRIG film-coated tablet 90 mg
- ALUNBRIG film-coated tablet 90 mg - 180 mg
- L04 - Inmunosupresores
- ALOFISEL suspension for injection 5 000 000 cells/ml
- ENTYVIO powder for solution for infusion 300 mg
- ENTYVIO PREFILLED PEN solution for injection 108 mg
- ENTYVIO PREFILLED SYRINGE solution for injection 108 mg
- N02 - Analgésicos
- INSTANYL nasal spray, solution 100 µg/dose
- INSTANYL nasal spray, solution 200 µg/dose
- INSTANYL nasal spray, solution 50 µg/dose